Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
publishDate:"[2019 TO 2021]"
journalStr:"ClinicalTrials.gov"
topic_facet:"Phase: Phase 2"
topic_facet:"Medical Condition: COVID-19"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+COVID-19%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+COVID-19%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+COVID-19%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
PubPharm (82)
1
A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE) : A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
2
Atovaquone for Treatment of COVID-19 : Atovaquone for Treatment of COVID-19
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
3
Coronavirus Disease 2019 (COVID-19) Antibody Plasma Research Study in Hospitalized Patients : IGHID 12021 - A Randomized, Phase II Study Comparing the Efficacy and Safety of Standard Versus High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody Plasma in Hospitalized Patients With COVID-19
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
4
Efficacy and Safety of hzVSF-v13 in Patients With COVID-19 Pneumonia : Efficacy and Safety of Intravenously Administered hzVSF-v13 in Patients With COVID-19 Pneumonia: a Phase II, Proof of Concept, Multicentre, Randomized, Parallel-group, Double-blind, Placebo-controlled Study
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
5
Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19 : A Phase 2 Randomized, Single-Blind Study of a Single Dose of Peginterferon Lambda-1a (Lambda) Compared With Placebo in Outpatients With Mild COVID-19
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
6
A Real World Study of Bamlanivimab in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19) : A Prospective Cohort Study to Evaluate the Real-world Effectiveness of Bamlanivimab in Participants With Mild-to-moderate COVID-19 at High Risk for Progressing to Severe Illness, With Matched Controls
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
7
Ozone Plasma on Lung Function and Inflammatory Parameters in Pulmonary Sequelae Associated With Coronavirus 19 Infection : Effect of Inhalation Administration of Ozone Plasma on Lung Function and Inflammatory Parameters in Patients With Pulmonary Sequelae Associated With Coronavirus 19 Infection (SARS-COV-2)
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
8
Crizanlizumab for Treating COVID-19 Vasculopathy : Crizanlizumab for Treating COVID-19 Vasculopathy
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
9
PERUCONPLASMA: Evaluating the Use of Convalescent Plasma as Management of COVID-19 : PERUCONPLASMA: Randomized Clinical Trial to Evaluate Safety and Efficacy of the Use of Convalescent Plasma in Hospitalized Patients With COVID-19
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
10
Donated Antibodies Working Against nCoV : A Randomized, Open-label, Adaptive, Proof-of-concept Clinical Trial of Donated Antibodies Working Against With COVID-19: DAWN-PLASMA
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
1
2
3
4
5
6
7
8
9
Nächster »
[9]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2019-2021
Filter aufheben
Zeitschrift: ClinicalTrials.gov
Filter aufheben
Thema: Phase: Phase 2
Filter aufheben
Thema: Medical Condition: COVID-19
Medienart
82
Aufsätze
82
E-Artikel
82
E-Ressourcen
Zeitschriftentitel
ClinicalTrials.gov
Thema
82
610
Medical Condition: COVID-19
Phase: Phase 2
82
Study Type: Interventional
38
Recruitment Status: Completed
17
COVID-19
16
Recruitment Status: Recruiting
10
Recruitment Status: Not yet recruiting
8
Recruitment Status: Terminated
8
Recruitment Status: Withdrawn
6
Pneumonia
4
Coronavirus Infections
3
Infection
1
Acute Lung Injury
1
Critical Illness
1
Lung Diseases
1
Lung Injury
1
Recruitment Status: Active, not recruiting
1
Recruitment Status: Enrolling by invitation
1
Respiratory Distress Syndrome
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2019-2021
56
2021
26
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
82
Englisch
Haven't found what you're looking for?
Wird geladen...